One Asset. Different Markets. Different Paths.
A global strategy provides direction, but it does not require every market to follow the same path. Sometimes creating the greatest global value requires finding very different local solutions.
The Situation
Consider an innovative medicine launching across multiple countries with a common clinical evidence package and a clear global value proposition.
The asset may be the same, but the environment is not. HTA requirements, payer priorities, clinical practice, patient populations, reimbursement mechanisms and willingness to manage uncertainty can vary substantially from one market to another.
A strategy that works well in one country may be difficult, slow or simply inappropriate in another.
The Assumption
Global organizations naturally seek consistency. A common strategy can strengthen positioning, simplify execution and help manage the relationships among pricing decisions across markets.
But consistency can become a constraint when it turns into an expectation that every market should pursue essentially the same solution.
The global objective and the local path are not the same thing.
The Possibility
The better question may be:
What does each market make possible while still advancing the broader global objective?
In one market, the best path may involve focusing initially on patients with the greatest unmet need. Somewhere else, it may involve managing uncertainty while additional evidence develops. Another market may offer flexibility across indications, pricing arrangements or the timing of access.
Those approaches can look very different while still supporting the same overall strategy.
What Changed
The focus shifts from replicating a global solution to establishing clear global objectives and giving markets the flexibility to find locally appropriate paths toward them.
That requires understanding which elements of the strategy truly need to remain consistent and where adaptation can create greater value.
It also means looking across markets. A decision that appears suboptimal when viewed within one country may make considerably more sense when its implications for launch timing, patient access, pricing and the broader international opportunity are considered together.
The Broader Lesson
Global strategy should create alignment without eliminating optionality.
The strongest international strategy is not necessarily the one that produces the greatest consistency. It is the one that understands the connections among markets while preserving enough flexibility to take advantage of what each market makes possible.
Same asset. Same global objective. Different paths.
Facing a similar strategic question?
These perspectives are informed by experience across assets, markets and different points in the product lifecycle. In a direct conversation, I can explore how the underlying principles and relevant experience might apply to your specific situation.
Let’s explore what might be possible.